MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-25-3808

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2026

Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.

Desmedt Christine, Nguyen Ha-Linh, Richard François, Linn Sabine, Metzger Fihlo Otto, Poncet Coralie, Wesseling Jelle, Aalders Kim, Delorenzi Mauro, Delaloge Suzette, Pierga Jean-Yves, Brain Etienne, Vrijaldenhoven Suzan, Van Baelen Karen, Maetens Marion, Rutgers Emiel, Piccart Martine, Van 't Veer Laura, Viale Giuseppe, Cardoso Fatima

СтатьяПеревод в очереди

Аннотация

PURPOSE: Invasive lobular carcinoma (ILC) is the second most common subtype of breast cancer after invasive breast cancer of no special type (IBC-NST). This retrospective analysis of the MINDACT trial investigated transcriptomic differences between estrogen receptor (ER)-positive/HER2-negative ILC and ER+/HER2- IBC-NST; classic and nonclassic ER+/HER2- ILC; and recurring and nonrecurring ER+/HER2- ILC in patients with a low genomic risk and either a low clinical/low genomic (cL/gL) or high clinical/low genomic (cH/gL) risk.

EXPERIMENTAL

DESIGN

We analyzed 4,262 ER+/HER2- tumors (63.7%; 464 ILC and 3,798 IBC-NST) with central pathology review. Differential gene expression analysis was adjusted for age and grade, followed by gene set enrichment analysis. Adjusted regression models evaluated associations of transcriptomic profiles with disease-free survival and distant recurrence-free survival.

RESULTS

An increased expression of CDH1 (E-cadherin) in IBC-NST compared with ILC was observed. ILC showed more uptake of extracellular lipid sources (LPL, CD36, LEP, and LEPR), whereas IBC-NST favored lipid synthesis (FASN). Decreased ER signaling, increased PI3K/Akt signaling, and differences related to the extracellular matrix were also observed in ILC. Classic and nonclassic ILC differed subtly, notably in cell-cycle regulation. In patients with ER+/HER2- ILC with a cL/gL risk, enrichment of apoptosis, inflammatory response, hypoxia, and oncogenic signaling (PI3K/Akt, Ras, and c-Myc) were associated with worse survival. In contrast, in the cH/gL group, associations between ILC transcriptomic features and survival were more subtle.

CONCLUSIONS

This represents the largest transcriptomic dataset for ILC from a clinical trial with central histology review. These findings may provide insights to refine treatment strategies and relapse risk assessment for patients with ILC.

Для цитирования: Desmedt Christine, Nguyen Ha-Linh, Richard François, Linn Sabine, Metzger Fihlo Otto, Poncet Coralie, Wesseling Jelle, Aalders Kim, Delorenzi Mauro, Delaloge Suzette, Pierga Jean-Yves, Brain Etienne, Vrijaldenhoven Suzan, Van Baelen Karen, Maetens Marion, Rutgers Emiel, Piccart Martine, Van 't Veer Laura, Viale Giuseppe, Cardoso Fatima. Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. DOI: 10.1158/1078-0432.ccr-25-3808.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.